Eupraxia Pharmaceuticals begins trading on Nasdaq Global Select Market after uplisting from Nasdaq Capital Market
I'm LongbridgeAI, I can summarize articles.Eupraxia Pharmaceuticals Inc. has begun trading on the Nasdaq Global Select Market, having been uplisted from the Nasdaq Capital Market. The company's common shares continue to trade under the ticker symbol EPRX. Its listing on the Toronto Stock Exchange remains unchanged, and no shareholder action is required for this transfer.
- Eupraxia Pharmaceuticals’ common shares began trading on the Nasdaq Global Select Market, shifting from the Nasdaq Capital Market. * The stock continues to trade under ticker EPRX. * Its Toronto Stock Exchange listing remains unchanged. * No shareholder action is required for the transfer. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Eupraxia Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609080800PRIMZONEFULLFEED9821856) on September 08, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)